Microbial Genomics as a Catalyst for Targeted Antivirulence Therapeutics

Virulence arresting drugs (VAD) are an expanding class of antimicrobial treatment that act to “disarm” rather than kill bacteria. Despite an increasing number of VAD being registered for clinical use, uptake is hampered by the lack of methods that can identify patients who are most likely to benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sintchenko, Vitali, Timms, Verlaine, Sim, Eby, Rockett, Rebecca, Bachmann, Nathan, O'Sullivan, Matthew, Marais, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076527/
https://www.ncbi.nlm.nih.gov/pubmed/33928102
http://dx.doi.org/10.3389/fmed.2021.641260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8076527/
https://www.ncbi.nlm.nih.gov/pubmed/33928102
http://dx.doi.org/10.3389/fmed.2021.641260

Ejemplares similares